News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Webinar | The Pathway to Driving Valuation for Your Laboratory: Your Roadmap to Achieving Success, and How to Sustain Growth Despite a Changing Lab Environment

Webinar – Held Thursday, June 28, 2018


Order DVD Now


The laboratory business as a whole is facing unprecedented economic challenges resulting from reimbursement cuts, changing regulatory and compliance requirements, and increased competition. To your lab individually, each and every one of these challenges means a direct impact to both your lab’s revenue and value.

As a result, you may be considering your strategic-positioning options: reorganizing, restructuring, merging/consolidating with another laboratory, or even selling. Regardless of the direction you may ultimately take, increasing revenue and operating margin— and thus maximizing valuation for your laboratory—is unquestionably one of the smartest business practices your lab can undertake.

But, why is it so vital for your lab to understand and maximize its value, even if you’re not in a buying or selling mode? To get the answers to this critical question, and to learn what you and your management team must do to help your lab survive and thrive in the current reality, Dark Daily is presenting an all-new webinar entitled, “The Pathway to Driving Valuation for Your Laboratory: Your Roadmap to Achieving Success, and How to Sustain Growth Despite a Changing Lab Environment,” held on Thursday, June 28 at 1:30 PM EDT.

This is a must-attend session for all laboratory owners, CEOs, administrators, and pathologists—anyone for whom the need to maintain the financial solvency of their lab organization is paramount, or who may be thinking of merging, consolidating, or affiliating with another laboratory or group either soon, or down the road.

The webinar will open with David Nichols, Founder of Nichols Management Group, York Harbor, ME. David will bring to the session his unique perspective as an advisor and participant on the transaction side of the business, and will provide an enlightening discussion on the primary areas in which a lab is place under scrutiny when being bought or sold, the key indicators that impact a lab’s valuation during the negotiation process, critical value drivers a seller needs to demonstrate in order to attract the right buyers, and much more.

Order DVD Now

Next up will be an incisive analysis from a highly-respected current laboratory industry executive, who also happens to be a former lab CEO. Your expert presenter, Vicki DiFrancesco, Chief Strategy Officer with XIFIN, Inc., San Diego, CA, has a unique understanding of the strategic and operational challenges your lab is facing and will cast an illuminating light on the market dynamics that are currently affecting your lab, along with informed and clear-cut recommendations on the most efficient and effective ways your lab can quickly improve its financial and operational performance.

Here’s just some of what you’ll learn during this indispensable 90-minute session

  • Understand the market factors that are creating serious financial challenges for your laboratory
  • Strategies you can implement now to significantly improve your market position
  • Learn the most important key performance indicators (KPIs) to ensure your lab’s success
  • Why optimizing reimbursements, not cost-cutting, is one of most successful ways to improve financial performance
  • Learn the steps your lab needs to take to optimize its reimbursements
  • Why it is crucial for your CFO to be fully engaged when it comes to monitoring reimbursement metrics and trends
  • Why compliance is so important to laboratory valuation, plus the components of an effective compliance program
  • The importance of revenue cycle management (RCM) as a valuation driver
  • Current trends in valuation and merger and acquisition activity and how to prepare for the future
  • Appreciate the specific challenges that should be addressed in any merger or consolidation plan, and much more!

Order DVD Now



DATE:                        Held Thursday, June 28, 2018

TIME:                         1:30 PM EDT; 12:30 PM CDT; 10:30 AM PDT

PLACE:                     Your computer and/or speakerphone

COST:                        $245.00

TO ORDER DVD:         Click here or call 512-264-7103


Whether your lab is in a buying or selling mode, or just preparing for what the future may hold—this timely webinar will provide you with the essential insights you need to increase revenue and operating margin, and effectively maximize your laboratory’s valuation.

Be sure to gather each and every one of your lab’s key team members together to participate!

How to Order:
1. Online
2. Call 512-264-7103

Your live registration includes:
• A site license to attend the webinar (invite as many people as you can fit around your conference table at no extra charge)
• A full transcript emailed to you soon after the conference
• The opportunity to pose specific questions, and connect directly with the speakers during the audience Q&A session

Order DVD today to take advantage of early-bird savings! For more information, call us at 512-264-7103.


Vicki DiFrancesco
Chief Strategy Officer
San Diego, CA

Vicki DiFrancesco is an accomplished diagnostics executive with more than 25 years in executive leadership positions, most recently serving as president and CEO of Pathology Inc., the west coast’s premier women’s health laboratory that was acquired by LabCorp in March 2016. Previously, she served as senior vice president, sales and marketing for Specialty Laboratories Inc.; executive vice president of sales and marketing for Spectrum Laboratory Network; and vice president of hospital sales and marketing at Quest Diagnostics, Inc. She has also held executive level positions with American Medical Laboratories and Laboratory Corporation of America. Vicki currently serves on the Board of Directors of PWNHealth, LLC. She holds a BS degree in biological sciences from California State University, Sacramento.

Richard Faherty
Managing Director
The Dark Intelligence Group, Inc.
Spicewood, TX

Richard Faherty is currently consulting primarily with laboratory services.  He was the Executive Vice President, Administration, for BioReference Laboratories (BRLI) until his retirement in July 2017.  He spent more than 20 years at BRLI overseeing general corporate affairs as well as all technology; he was President of PSIMedica (the Company’s clinical knowledge management division) and the creator of CareEvolve, the Company’s connectivity solution up until its recent sale to ELLKAY.  Prior to BRLI, Faherty worked in financial technology at S&P Comstock and A-T Financial Services, as well as a Y2K project manager for MetLife. He has been associated with the clinical laboratory business since 1986 when he began consulting for GenCare Biomedical (later acquired by BioReference). Faherty is a graduate of the University of Notre Dame and Fordham Law School. After practicing law for nearly ten years, he became involved in Information Technology and has been involved with complex data management, networking solutions, and application and data distribution since that time.